Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Vanta Bioscience Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Vanta Bioscience Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Vanta Bioscience has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Vanta Bioscience - Board Meeting Outcome for Outcome Of Board Meeting Held On 06.05.2025
-
Vanta Bioscience - Intimation Regarding Receipt Of GLP Re-Certification For The Facility Of The Company In Gummidipundi, Tami
Key fundamentals
Evaluate the intrinsic value of Vanta Bioscience Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 45.1729 | 45.5003 | 44.7576 | 37.2079 | 35.7512 |
| Liabilities | 45.1729 | 45.5003 | 44.7576 | 37.2079 | 35.7512 |
| Equity | 6.312 | 6.312 | 6.312 | 6.312 | 6.312 |
| Gross Profit | 3.6522 | -0.4755 | 3.4018 | 3.8934 | 4.3163 |
| Net Profit | 0.051 | -4.2354 | 0.0785 | 0.4702 | 0.978 |
| Cash From Operating Activities | 4.5421 | 0.6447 | 6.7025 | 10.9111 | 2.9525 |
| NPM(%) | 0.59 | -81.9 | 0.83 | 4.68 | 6.92 |
| Revenue | 8.5579 | 5.1709 | 9.3498 | 10.0383 | 14.113 |
| Expenses | 4.9056 | 5.6465 | 5.948 | 6.1448 | 9.7966 |
| ROE(%) | 0.36 | -30.4 | 0.56 | 3.37 | 7.02 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Vanta Bioscience Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 810.05 | -1.12 | 26.88 | 13.61 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 74.39 | 0.39 | 308.58 | 49.60 | 14.01 | 0.68 |
| Bharat Immunological and Biologicals Corporation Ltd | 25.66 | -5.45 | 0.00 | 102.98 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 698.00 | -1.87 | 0.00 | 46.77 | -687.11 | 0.00 |
Company Info
The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201.
The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201.
Read More
Parent Organisation
Vanta Bioscience Ltd.
Founded
29/04/2016
Managing Director
Mr.Dopesh Raja Mulakala
NSE Symbol
FAQ
The current price of Vanta Bioscience Ltd is
The 52-week high for Vanta Bioscience Ltd is
The market capitalization of Vanta Bioscience Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Vanta Bioscience Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Vanta Bioscience Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vanta Bioscience Ltd shares.
The CEO of Vanta Bioscience Ltd is Mr.Dopesh Raja Mulakala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
